RR Donnelley Hit With Class Suit Claiming Poison Pill Bias
R.R. Donnelley & Sons Co. stockholders have opened a class suit in Delaware's Chancery Court accusing the company of bias in shielding a purportedly lower priced, $2.1 billion take private deal...To view the full article, register now.
Already a subscriber? Click here to view full article